维普中文期刊产品整合服务
85篇 您的检索式:作者名="TIBALDI E"
    题名 作者 年代 出处 被引量
1Crucial role of HsPg0 in the Akt-dependent promotion of angiogenic-like effect of glucose-regulated protein94 ( Grp94 ) -IgG complexes显示文摘Tramentozzi E Tibaldi E Brunati AM 2011J Cell Mol Meal2011,15,12:1
2Pharmacogenetic study of patients with advanced non-small cell lung cancer(NSCLC)treated with second-line pemetrexed or pemetrexed-carboplatin显示文摘Tiseo M Giovannetti E Tibaldi C 2012Lung Cancer2012,78,1:1
3Cisplatin-vindesine-mitomyvin (MVP) Vs cisplatin-ifosfamide-vinorelbine (PIN) Vs carboplatin vinoprelbine (CaN) in patients with advanced nonsmall cell lung cancer: a FONICAP randomized phase study显示文摘 Tibaldi C Ardizzoni A 1998Br J Cancer1998,77,12:1
4Dietary threonine requirement of juvenile European sea bass (Dicentrarchus labrax) 显示文摘Tibaldi E Tulli F 1999Aquac1999,177,:1
5The utility of theNecessity-Concems Framework in explaining treatment non-adherence in four chronic illness groups in Italy显示文摘Tibaldi G Clatworthy J Torchio E 2009ChronicIlln2009,5,2:1
6Impact of cytidine deaminase polymorphisms on toxicity after gemcitabine:The question is still ongoing显示文摘Giovannetti E Tibaldi C Falcone A 2010J Clin Oncol2010,28,14:1
7Inherited germline T790M mutation and somatic epidermal growth factor re- ceptor mutations in non-small cell lung cancer patients显示文摘Tibaldi C Giovannetti E Vasile E 2011J Thorac Oncol2011,6,2:1
8Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/eisplatiwtreated advanced non small cell lung cancer patients显示文摘Tibaldi C Giovannetti E Vasile E 2008Clin Cancer Res2008,14,6:1
9Sequential chemoradiation therapy with vinorelbine, ifosfamide, cisplatin in stage ⅢB nn-small cell lung cancer:a phase Ⅱstudy显示文摘 Silvano G Tibaldi C 2000Semin Oncol2000,27,:1
10First line chemothera-py with planned sequential administration of gemcitabine fol-lowed by docetaxel in elderly advanced non-small-cell lung canc-er patients:a multicenter phase II study显示文摘Tibaldi C Vasile E Antonuzzo A 2008Br J Cancer2008,98,:1
11Arginine requirement and effect of different dietary arginine and lysine levels for fingerling sea bass (Dicentrarchus labrax)显示文摘Tibaldi E Tulli F Lanari D 1994Aquaculture1994,127,:1
12Voluntary pregnancy termination among women with H1 V in the HAART era(2002-2008):a case series from a national study显示文摘Floridia M Tamburrini E Tibaldi C 0,,:1
13Effects of fertilization and stocking rate on the performance of Penaeus japonicus (Bate) in pond culture 显示文摘LANARI D BALLESTRAZZI R TIBALDI E 1989Aquaculture1989,83,34:1
14Correlation of CDA, ERCC1, and XPD Polymorphisms with Response and Survival in Gemeitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer patients显示文摘Tibaldi C Giovannetti E Vasile E 2008Clin Cancer Res2008,14,8:1
15Cisplatin plus gemcit-abine as adjuvant chemotherapy for radically resected non-small-cell lung cancer: a pilot study 显示文摘Tibaldi C Mazzoni E Arcabasso G 2009Clin Lung Cancer2009,10,1:1
16Dietary threonine requirement of juvenile European sea bass(Dicentrarchus labrax)显示文摘Tibaldi E Tulli F 1999Aquaculture1999,175,:1
17A note on the use of plasma urea level to vali- date the arginine requirement assessed by growth data in seabass(Dicentrarchus labrax) 显示文摘Tibaldi E Tulli F Lanri D 1995Journal of Applied Ichthyology1995,11,:1
18Cytochrome P450 1B1 (CYP1B1) polyrnorphisms are associated with clinical outcome of doeetaxel in non -small cell lung cancer (NSCLC) patients显示文摘Vasile E Tibaldi C Leon GL 2015J Cancer Res Clin Oncol2015,141,:1
19Arginine requirement and effect of different dietary arginine and lysine levels for fingerling sea bass( Dicentrarchus labrax) 显示文摘Tibaldi E Tulli F Lanari D 1994Aquaculture1994,127,:1
20Correlation of CDA,ER- CCl,and XPD polymorphisms with response and survival in geme- itabine/cisplatin-treated advanced non-small cell lung cancer patients 显示文摘Tibaldi C Giovannetti E 'qasile E 2008Clin Cancer Res2008,14,6:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费